Menopause and Heart Health: Understanding the Impact of Hormonal Changes on Cardiovascular Risk

Written and edited by Sarah Bonza MD, MPH, FAAFP, MSCP, DipABLM, NBC-HWC

As women transition through menopause, the decline in estrogen and progesterone levels can significantly affect cardiovascular health. Understanding these hormonal changes and their implications is crucial for promoting not only a longer life but also a healthier one.

Hormonal Shifts and Cardiovascular Impact

Estrogen plays a vital role in maintaining vascular health by promoting the production of nitric oxide, a molecule that helps relax blood vessels, thereby improving blood flow and reducing the risk of hypertension. [1] It also aids in regulating lipid profiles by lowering low-density lipoprotein (LDL) cholesterol, which, when elevated, can lead to the formation of fatty deposits in arteries, increasing the risk of atherosclerosis and heart disease. As estrogen levels decline during menopause, these protective effects diminish, leading to increased vascular stiffness and unfavorable changes in lipid profiles.[2]

Progesterone, when combined with estrogen in hormone replacement therapy (HRT), can influence lipid metabolism. Some progestogens may attenuate the beneficial effects of estrogens on lipid profiles, depending on their androgenicity. Progestogens with greater androgenic activity have been found to diminish estrogen's positive impact on lipid metabolism. [3]

Epidemiology of Cardiovascular Disease in Postmenopausal Women

Cardiovascular disease (CVD) is the leading cause of death among women in the United States, accounting for twice as many deaths as all forms of cancer combined. Rates of CVD mortality increase sharply with age in both men and women, with higher rates in men than women at all ages [4].

Atypical Cardiovascular Symptoms in Women

Women often present with atypical cardiovascular symptoms, which can lead to underdiagnosis or misdiagnosis. Symptoms such as neck, jaw, shoulder, upper back, or abdominal discomfort, shortness of breath, arm pain, nausea, vomiting, sweating, dizziness, fatigue, and even heartburn can be indicative of heart issues. Recognizing these symptoms is vital for timely and accurate [5].

Emerging Approaches in Functional Cardiovascular Health and Screening

Advancements in functional medicine offer proactive approaches to cardiovascular health during menopause. Advanced lipid testing provides a detailed analysis of lipid particles, offering a more comprehensive risk assessment than standard lipid panels. Endothelial function tests assess the health of the blood vessel lining, serving as an early indicator of cardiovascular risk. Additionally, measuring inflammatory markers such as C-reactive protein (CRP) can help identify underlying inflammation that contributes to cardiovascular disease.[6]

Menopause: A Time for Empowerment

Menopause is a critical period to focus on health and well-being. By understanding the cardiovascular risks associated with hormonal changes, women can take proactive steps to protect their heart health. Lifestyle modifications, including a balanced diet, regular physical activity, stress management, and appropriate medical interventions, can significantly reduce cardiovascular risk and promote a healthy, vibrant life.

At Bonza Health, we specialize in menopause care that integrates hormone therapy, functional medicine, and lifestyle strategies to address cardiovascular health. Schedule an appointment with us to discuss personalized approaches to maintaining your heart health during this critical time.

Sign up for Fullscript to shop professional-grade perimenopause supplements.

REFERENCES

[1] S. Novella, A. P. Dantas, G. Segarra, P. Medina, and C. Hermenegildo, “Vascular Aging in Women: is Estrogen the Fountain of Youth?,” Jan. 01, 2012, Frontiers Media. doi: 10.3389/fphys.2012.00165.

[2] “Menopause and cardiovascular disease.” doi: 10.4103/0976-7800.261983.

[3] “Vascular Effects of Estrogenic Menopausal Hormone Therapy.” doi: 10.2174/157488712799363253.

[4] L. Mosca, E. Barrett‐Connor, and N. K. Wenger, “Sex/Gender Differences in Cardiovascular Disease Prevention,” Nov. 07, 2011, Lippincott Williams & Wilkins. doi: 10.1161/circulationaha.110.968792.

[5] J. P. Ornato and M. M. Hand, “Warning Signs of a Heart Attack,” Sep. 11, 2001, Lippincott Williams & Wilkins. doi: 10.1161/hc2501.093258.

[6] H. A. R. Hadi, C. S. Carr, and J. A. Suwaidi, “Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome.,” Jan. 01, 2005. Accessed: Jan. 2025. [Online]. Available: https://doaj.org/article/101ef2e19a654da8873f6c85da48c628